Works matching IS 19466234 AND DT 2019 AND VI 11 AND IP 477

Results: 9
    1

    The more (mutations), the better.

    Published in:
    Science Translational Medicine, 2019, v. 11, n. 477, p. N.PAG, doi. 10.1126/scitranslmed.aaw5320
    By:
    • Lujambio, Amaia
    Publication type:
    Article
    2

    Erratum for the Research Article: "The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activation" by D. P. Kodack, V. Askoxylakis, G. B. Ferraro, Q. Sheng, M. Badeaux, S. Goel, X. Qi, R. Shankaraiah, Z. A. Cao, R. R. Ramjiawan, D. Bezwada, B. Patel, Y. Song, C. Costa, K. Naxerova, C. S. F. Wong, J. Kloepper, R. Das, A. Tam, J. Tanboon, D. G. Duda, C. R. Miller, M. B. Siegel, C. K. Anders, M. Sanders, M. V. Estrada, R. Schlegel, C. L. Arteaga, E. Brachtel, A. Huang, D. Fukumura, J. A. Engelman, R. K. Jain

    Published in:
    2019
    Publication type:
    Correction Notice
    3

    Transforming medicine with the microbiome.

    Published in:
    Science Translational Medicine, 2019, v. 11, n. 477, p. N.PAG, doi. 10.1126/scitranslmed.aaw1815
    By:
    • Zmora, Niv;
    • Soffer, Eliran;
    • Elinav, Eran
    Publication type:
    Article
    4
    5
    6

    Durable anticancer immunity from intratumoral administration of IL-23, IL-36γ, and OX40L mRNAs.

    Published in:
    Science Translational Medicine, 2019, v. 11, n. 477, p. N.PAG, doi. 10.1126/scitranslmed.aat9143
    By:
    • Hewitt, Susannah L.;
    • Bai, Ailin;
    • Bailey, Dyane;
    • Ichikawa, Kana;
    • Zielinski, John;
    • Karp, Russell;
    • Apte, Ameya;
    • Arnold, Kristen;
    • Zacharek, Sima J.;
    • Iliou, Maria S.;
    • Bhatt, Khushbu;
    • Garnaas, Maija;
    • Musenge, Faith;
    • Davis, Ashley;
    • Khatwani, Nikhil;
    • Su, Stephen V.;
    • MacLean, Graham;
    • Farlow, Samuel J.;
    • Burke, Kristine;
    • Frederick, Joshua P.
    Publication type:
    Article
    7

    Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastoma.

    Published in:
    Science Translational Medicine, 2019, v. 11, n. 477, p. N.PAG, doi. 10.1126/scitranslmed.aau1099
    By:
    • Gamble, Laura D.;
    • Purgato, Stefania;
    • Murray, Jayne;
    • Xiao, Lin;
    • Yu, Denise M. T.;
    • Hanssen, Kimberley M.;
    • Giorgi, Federico M.;
    • Carter, Daniel R.;
    • Gifford, Andrew J.;
    • Valli, Emanuele;
    • Milazzo, Giorgio;
    • Kamili, Alvin;
    • Mayoh, Chelsea;
    • Liu, Bing;
    • Eden, Georgina;
    • Sarraf, Sara;
    • Allan, Sophie;
    • Di Giacomo, Simone;
    • Flemming, Claudia L.;
    • Russell, Amanda J.
    Publication type:
    Article
    8

    A biologic scaffold–associated type 2 immune microenvironment inhibits tumor formation and synergizes with checkpoint immunotherapy.

    Published in:
    Science Translational Medicine, 2019, v. 11, n. 477, p. N.PAG, doi. 10.1126/scitranslmed.aat7973
    By:
    • Wolf, Matthew T.;
    • Ganguly, Sudipto;
    • Wang, Tony L.;
    • Anderson, Christopher W.;
    • Sadtler, Kaitlyn;
    • Narain, Radhika;
    • Cherry, Christopher;
    • Parrillo, Alexis J.;
    • Park, Benjamin V.;
    • Wang, Guannan;
    • Pan, Fan;
    • Sukumar, Saraswati;
    • Pardoll, Drew M.;
    • Elisseeff, Jennifer H.
    Publication type:
    Article
    9

    Dynamics of circulating TNF during adalimumab treatment using a drug-tolerant TNF assay.

    Published in:
    Science Translational Medicine, 2019, v. 11, n. 477, p. N.PAG, doi. 10.1126/scitranslmed.aat3356
    By:
    • Berkhout, Lea C.;
    • l'Ami, Merel J.;
    • Ruwaard, Jill;
    • Hart, Margreet H.;
    • Heer, Pleuni Ooijevaar-de;
    • Bloem, Karien;
    • Nurmohamed, Michael T.;
    • van Vollenhoven, Ronald F.;
    • Boers, Maarten;
    • Alvarez, Daniel F.;
    • Smith, Catherine H.;
    • Wolbink, Gerrit J.;
    • Rispens, Theo
    Publication type:
    Article